Bank of America’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-532,600
| Closed | -$52M | – | 7440 |
|
|
2025
Q3 | $52M | Buy |
532,600
+237,200
| +80% | +$24.6M | ﹤0.01% | 1730 |
|
|
2025
Q2 | $31.7M | Sell |
295,400
-584,300
| -66% | -$59.1M | ﹤0.01% | 2094 |
|
|
2025
Q1 | $88.7M | Sell |
879,700
-268,300
| -23% | -$27M | 0.01% | 1158 |
|
|
2024
Q4 | $103M | Sell |
1,148,000
-25,000
| -2% | -$2.2M | 0.01% | 1004 |
|
|
2024
Q3 | $98.3M | Buy |
1,173,000
+58,000
| +5% | +$4.57M | 0.01% | 1078 |
|
|
2024
Q2 | $85.9M | Buy |
1,115,000
+292,300
| +36% | +$21.4M | 0.01% | 1101 |
|
|
2024
Q1 | $56.3M | Buy |
822,700
+74,900
| +10% | +$4.82M | 0.01% | 1397 |
|
|
2023
Q4 | $43.2M | Buy |
747,800
+20,000
| +3% | +$1.07M | ﹤0.01% | 1476 |
|
|
2023
Q3 | $38.4M | Buy |
727,800
+175,200
| +32% | +$9.19M | ﹤0.01% | 1459 |
|
|
2023
Q2 | $29.9M | Buy |
552,600
+203,200
| +58% | +$10.6M | ﹤0.01% | 1674 |
|
|
2023
Q1 | $17.5M | Buy |
349,400
+189,700
| +119% | +$8.94M | ﹤0.01% | 2252 |
|
|
2022
Q4 | $7.39M | Buy |
159,700
+72,500
| +83% | +$3.14M | ﹤0.01% | 2983 |
|
|
2022
Q3 | $3.38M | Buy |
87,200
+76,500
| +715% | +$3.07M | ﹤0.01% | 3764 |
|
|
2022
Q2 | $399K | Sell |
10,700
-57,100
| -84% | -$2.32M | ﹤0.01% | 5589 |
|
|
2022
Q1 | $3M | Sell |
67,800
-79,300
| -54% | -$3.44M | ﹤0.01% | 4172 |
|
|
2021
Q4 | $6.25M | Sell |
147,100
-145,700
| -50% | -$6.12M | ﹤0.01% | 3423 |
|
|
2021
Q3 | $12.7M | Sell |
292,800
-209,300
| -42% | -$9.26M | ﹤0.01% | 2594 |
|
|
2021
Q2 | $21.5M | Buy |
502,100
+387,700
| +339% | +$16.3M | ﹤0.01% | 2079 |
|
|
2021
Q1 | $4.42M | Sell |
114,400
-8,600
| -7% | -$325K | ﹤0.01% | 3520 |
|
|
2020
Q4 | $4.42M | Buy |
123,000
+111,100
| +934% | +$4M | ﹤0.01% | 3246 |
|
|
2020
Q3 | $455K | Hold |
11,900
| – | – | ﹤0.01% | 4782 |
|
|
2020
Q2 | $418K | Hold |
11,900
| – | – | ﹤0.01% | 4740 |
|
|
2020
Q1 | $388K | Sell |
11,900
-416,400
| -97% | -$16.3M | ﹤0.01% | 4684 |
|
|
2019
Q4 | $19.4M | Buy |
428,300
+268,300
| +168% | +$11.2M | ﹤0.01% | 1911 |
|
|
2019
Q3 | $6.51M | Sell |
160,000
-2,100
| -1% | -$89K | ﹤0.01% | 2948 |
|
|
2019
Q2 | $6.97M | Buy |
162,100
+140,800
| +661% | +$5.42M | ﹤0.01% | 2906 |
|
|
2019
Q1 | $818K | Sell |
21,300
-171,600
| -89% | -$6.55M | ﹤0.01% | 4672 |
|
|
2018
Q4 | $6.82M | Buy |
192,900
+192,800
| +192,800% | +$6.99M | ﹤0.01% | 2676 |
|
|
2018
Q3 | $4K | Sell |
100
-50,000
| -100% | -$1.75M | ﹤0.01% | 6863 |
|
|
2018
Q2 | $1.64M | Buy |
50,100
+50,000
| +50,000% | +$1.51M | ﹤0.01% | 4124 |
|
|
2018
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 6840 |
|
|
2017
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 6849 |
|
|
2017
Q3 | $3K | Buy |
+100
| New | +$2.76K | ﹤0.01% | 6808 |
|
|
2016
Q2 | – | Sell |
-43,700
| Closed | -$822K | – | 7126 |
|
|
2016
Q1 | $822K | Buy |
+43,700
| New | +$768K | ﹤0.01% | 4243 |
|
|
2015
Q3 | – | Sell |
-120,000
| Closed | -$2.12M | – | 7210 |
|
|
2015
Q2 | $2.12M | Buy |
+120,000
| New | +$2.14M | ﹤0.01% | 3403 |
|
|
2015
Q1 | – | Sell |
-3,100
| Closed | -$41K | – | 7074 |
|
|
2014
Q4 | $41K | Sell |
3,100
-5,000
| -62% | -$63.9K | ﹤0.01% | 6448 |
|
|
2014
Q3 | $96K | Buy |
8,100
+3,900
| +93% | +$49.1K | ﹤0.01% | 6036 |
|
|
2014
Q2 | $54K | Buy |
4,200
+2,700
| +180% | +$35.1K | ﹤0.01% | 6597 |
|
|
2014
Q1 | $20K | Sell |
1,500
-14,800
| -91% | -$194K | ﹤0.01% | 6906 |
|
|
2013
Q4 | $196K | Buy |
16,300
+1,200
| +8% | +$14.2K | ﹤0.01% | 5612 |
|
|
2013
Q3 | $177K | Sell |
15,100
-16,900
| -53% | -$183K | ﹤0.01% | 5549 |
|
|
2013
Q2 | $297K | Buy |
+32,000
| New | +$271K | ﹤0.01% | 5243 |
|
Other funds holding BSX
VCM
VPM
Bank of America's BSX Position: Q1 2026 in Review
Bank of America reduced its Boston Scientific (BSX) stake by 9.4% in Q1 2026, selling an estimated $189M and leaving 22,756,646 shares worth $1.43B. The position accounts for 0.1% of the portfolio, ranked #187.
Bank of America first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.64B in Q2 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Bank of America held 22,756,646 shares of Boston Scientific worth $1.43B as of Q1 2026.
- Bank of America sold 2,358,539 Boston Scientific shares in Q1 2026, an estimated $189M.
- Boston Scientific made up 0.1% of Bank of America's portfolio in Q1 2026, its #187 holding.
- Bank of America first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Boston Scientific position peaked at $3.64B in Q2 2025.
- 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.